26.04.2006 11:02:00

Longs Drug Stores Announces Karen Stout Executive Vice President and Chief Operating Officer

WALNUT CREEK, Calif., April 26 /PRNewswire-FirstCall/ -- Longs Drug Stores Corporation today announced that Karen Stout has been named Executive Vice President and Chief Operating Officer, effective May 15, 2006. Reporting directly to Warren F. Bryant, Chairman, President and Chief Executive Officer, Stout will be responsible for store operations, marketing, merchandising, construction and loss prevention at Longs Drugs.

Stout has more than 27 years of retail experience. Immediately prior to joining Longs Drugs, Stout served as Executive Vice President, Merchandising for BJ's Wholesale Club, Inc. Prior to her most recent position, Stout was President of two divisions of the Atlantic & Pacific Tea Company. From 1978 to 2000, Stout was employed by Harris Teeter Supermarkets, Inc., where she advanced through a succession of management positions, rising to Senior Vice President, Operations in 1997. Stout earned a Bachelor's degree from the University of North Carolina and an MBA from Queens College.

About Longs Drug Stores

Headquartered in Walnut Creek, California, Longs Drug Stores Corporation is one of the most recognized retail drug store chains on the West Coast and in Hawaii. With 477 stores, Longs Drugs provide expert pharmacy services and a wide assortment of merchandise focusing on health, wellness, beauty and convenience. Longs also provides pharmacy benefit management services and Medicare beneficiary prescription drug plans through its wholly-owned subsidiary, RxAmerica, LLC. Additional information about Longs and its services is available at http://www.longs.com/ and more information about RxAmerica is available at http://www.rxamerica.com/.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu CVS Health Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

CVS Health Corp 43,83 -1,19% CVS Health Corp

Indizes in diesem Artikel

S&P 600 SmallCap 935,46 -0,94%